Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd

This study tests a new treatment called SYS6055 for people with aggressive B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses specially designed cells to target and attack cancer cells. The trial will check if it is safe, what dose works b…